German consortium for frontotemporal lobar degeneration;Konsortium zur Erforschung der frontotemporalen Lobärdegeneration

Nervenarzt

Volumn 82, Issue 8, 2011, Pages 1002-1005

  Otto, M ^a   Ludolph, A C ^a   Landwehrmeyer, B ^a   Forstl H ^b   Diehl Schmid, J ^b   Neumann, M ^c   Kretzschmar, H A ^d   Schroeter, M ^e   Kornhuber, J ^f   Danek, A ^d  

^a UNIVERSITY OF ULM   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF MUNICH   (Germany)

^e MAX PLANCK INSTITUTE   (Germany)

^f UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Aetiology; Classification; Early diagnosis; Frontotemporal lobar degeneration; Risk genes

Indexed keywords

TAR DNA BINDING PROTEIN; TAU PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CORTICOBASAL DEGENERATION; FOLLOW UP; FRONTOTEMPORAL DEMENTIA; GERMANY; HUMAN; LANGUAGE; PATHOPHYSIOLOGY; PROGRESSIVE NONFLUENT APHASIA; PROGRESSIVE SUPRANUCLEAR PALSY; SEMANTIC DEMENTIA;

ATROPHY; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; DNA-BINDING PROTEINS; EARLY DIAGNOSIS; FRONTAL LOBE; FRONTOTEMPORAL LOBAR DEGENERATION; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; PROGNOSIS; RISK FACTORS; TAU PROTEINS; TDP-43 PROTEINOPATHIES; TEMPORAL LOBE;

EID: 80755145995     PISSN: 00282804     EISSN: 14330407     Source Type: Journal    
DOI: 10.1007/s00115-011-3261-3     Document Type: Article

References (21)

1. Danek A (2011) Pick-Komplex: frontotemporale Lobärdegenerationen. In: Förstl H (Hrsg) Demenzen in Theorie und Praxis. Springer, Berlin Heidelberg, S155-172
2. Danek A, Diehl-Schmid J, Grimmer T et al (2009) Frontotemporal lobar degeneration. Part 1: diagnosis and treatment. Fortschr Neurol Psychiatr 77:169-177
3. Diehl-Schmid J, Forstl H, Perneczky R et al (2008) A 6-month, open-label study of memantine in patients with frontotemporal dementia. Int J Geriatr Psychiatry 23:754-759
4. Diehl-Schmid J, Grimmer T, Drzezga A et al (2007) Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Neurobiol Aging 28:42-50 (Pubitemid 44791637)
5. Diehl-Schmid J, Pohl C, Perneczky R et al (2006) Behavioral disturbances in the course of frontotemporal dementia. Dement Geriatr Cogn Disord 22:352-357 (Pubitemid 44651451)
6. Foulds P, McAuley E, Gibbons L et al (2008) TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration. Acta Neuropathol 116:141-146
7. Foulds PG, Davidson Y, Mishra M et al (2009) Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration. Acta Neuropathol 118:647-658
8. Ghidoni R, Benussi L, Glionna M et al (2008) Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. Neurology 71:1235-1239
9. Gorno-Tempini ML, Hillis AE, Weintraub S et al (2011) Classification of primary progressive aphasia and its variants. Neurology 76:1006-1014
10. Johnson JK, Diehl J, Mendez MF et al (2005) Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch Neurol 62:925-930 (Pubitemid 40973454)
11. Mackenzie IR, Neumann M, Bigio EH et al (2010) Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 119:1-4
12. Neumann M, Rademakers R, Roeber S et al (2009) A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 132:2922-2931
13. Neumann M, Sampathu DM, Kwong LK et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130-133 (Pubitemid 44547757)
14. Otto M, Lewczuk P, Wiltfang J (2008) Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases. Methods 44:289-298 (Pubitemid 351406506)
15. Piguet O, Hornberger M, Mioshi E, Hodges JR (2011) Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management. Lancet Neurol 10:162-172
16. Rabinovici GD, Miller BL (2010) Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs 24:375-398
17. Riemenschneider M, Wagenpfeil S, Diehl J et al (2002) Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration. Neurology 58:1622-1628 (Pubitemid 34602892)
18. Schroeter ML, Raczka K, Neumann J, von Cramon YD (2007) Towards a nosology for frontotemporal lobar degenerations - a meta-analysis involving 267 subjects. Neuroimage 36:497-510 (Pubitemid 46907633)
19. Steinacker P, Hendrich C, Sperfeld AD et al (2009) Concentrations of beta-amyloid precursor protein processing products in cerebrospinal fluid of patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration. J Neural Transm 116:1169-1178
20. Steinacker P, Hendrich C, Sperfeld AD et al (2008) TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neurol 65:1481-1487
21. Swieten JC van, Heutink P (2008) Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. Lancet Neurol 7:965-974